谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

SELECT-AML-1: Phase 2 Randomized Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Adult Patients with Previously Untreated AML with RARA Overexpression, Who Are Ineligible for Standard Induction Therapy

Uma Borate,Christine McMahon,Pierre Fenaux,Mael Heiblig,Pierre Peterlin,Brian Ball, Sylvain Chantepie,Alireza Eghtedar,Suman Kambhampati,Melhem Solh, Jose Torregrosa-Diaz,Thorsten Braun, Stephan de Botton,James Dugan,Jonathan Feld,Marie-Pierre Gourin,Arnaud Pigneux,Jean-Baptiste Robin,Gary Schiller,Eytan Stein,David Roth,Kristen Baker,Sofia Paul,Michael Kelly,Daniel Pollyea,Thomas Cluzeau

Clinical Lymphoma Myeloma and Leukemia（2024）

引用 0|浏览2
关键词
AML,tamibarotene,venetoclax,azacitidine,unfit AML,RARA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要